Get in Touch

Editorial contact

Prescribed Retatrutide is an independent editorial project. We accept inquiries related to:

• Citation corrections or updates. If a cited study has been retracted, corrected, or superseded, we want to know.
• Editorial feedback. Factual errors, misquoted figures, or inaccurate characterizations of trial data.
• Media and licensing. Use of this site's editorial summaries in other publications.

We do not respond to inquiries about purchasing, sourcing, prescribing, or using retatrutide. We do not provide medical consultations or clinical referrals. For clinical trial enrollment, see ClinicalTrials.gov.

Disclaimer

This site is an independent editorial project. It is not affiliated with Eli Lilly and Company, any clinical trial site, any pharmacy, or any telehealth provider. The content is editorial commentary on publicly available research. Nothing on this site constitutes medical advice, a prescription, or a recommendation for any use of any compound. Retatrutide is an investigational drug — not approved by any regulatory agency as of mid-2026.